Kronox Lab Sciences Limited has informed the stock exchanges of an upcoming board meeting scheduled for Thursday, May 21, 2026, in accordance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and other applicable regulations. The meeting has been convened to consider and approve key financial and corporate matters pertaining to the financial year ended March 31, 2026.

Board Meeting Agenda

The board meeting on May 21, 2026 will take up the following items for consideration and approval:

The company's intimation was submitted on May 18, 2026, and is in continuation of its previous announcement to the exchanges. The board will deliberate on the audited standalone financials covering both the fourth quarter and the full financial year ended March 31, 2026, alongside a potential dividend recommendation for equity shareholders.

Trading Window Closure

In line with applicable insider trading regulations, Kronox Lab Sciences has also notified that the trading window for directors, officers, and designated employees of the company is closed with effect from April 01, 2026. The trading window will continue to remain closed until 48 hours after the declaration of the audited standalone financial results for the quarter and year ended March 31, 2026.

The intimation was signed by Nikhil Goswami, Company Secretary & Compliance Officer (Membership No. A68272), on behalf of Kronox Lab Sciences Limited.

KRONOX Lab Sciences Limited has issued a regulatory clarification to stock exchanges regarding significant movement in its share price, stating that the company is not aware of any specific reasons behind the price fluctuation. The clarification was submitted on April 08, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Regulatory Compliance Statement

In its filing to both National Stock Exchange of India Limited and BSE Limited, the company emphasized its consistent adherence to disclosure requirements. The management stated that it has always been disclosing all material information that has a bearing on the company's operations and performance, including price-sensitive information and other necessary disclosures within stipulated timeframes.

Management Position on Price Movement

The company's management clarified that it is not connected with the movement in share prices and attributed the fluctuation to market-driven factors. Company Secretary and Compliance Officer Nikhil Goswami, who signed the clarification, reiterated the company's commitment to maintaining compliance with listing regulations and other applicable laws.

Corporate Information

KRONOX Lab Sciences Limited operates from its corporate office in Block No. 284, Village Dabhasa, Taluka Padra, District Vadodara, Gujarat State. The company's registered office is located at Block No. 353, Village Ekalbara in the same taluka and district. The company maintains its commitment to transparency and regulatory compliance as outlined in the SEBI listing regulations.